 NEW YORK, Jan. 11, 2021 GLOBE NEWSWIRE -- Delcath Systems, Inc. Nasdaq: DCTH , an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver, announced today that management will present at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference. 